NIH-funded research R01 grant

How titin affects diaphragm weakness during ventilator use

Official title: Role of titin in the pathophysiology of diaphragm weakness during mechanical ventilation

Funded at University of Arizona · NIH-11192344 · Data updated 2026-11-12

This project looks at whether changes in the muscle protein titin make the breathing muscle (diaphragm) weaker in people on mechanical ventilators.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Arizona
NIH-funded
Lab location1 site (Tucson, United States)
Project startJanuary 1, 2014
Project endJuly 31, 2027
Funding year2025
Award (this year)$586,463
NIH project number5R01HL121500-12
Project IDNIH-11192344 on NIH RePORTER

Who could benefit from this research

Could help

Adults in the ICU who are receiving mechanical ventilation and can safely provide consent (or have a proxy consent) and undergo a diaphragm biopsy would be the ideal candidates.

Less likely to help

People who are not on mechanical ventilation or whose breathing problems come from non-muscular causes are unlikely to benefit directly from this research.

What this research studies

If you or a loved one is in the ICU on a ventilator, researchers will study small diaphragm tissue samples to understand why the breathing muscle weakens quickly when it is unloaded. They will measure how the main muscle proteins (myosin and actin) behave and whether titin helps release myosin from an inactive state. The team combines muscle-force testing with X-ray diffraction and biochemical assays on patient biopsy samples. Their approach aims to map the chain of events that leads to ventilator-induced diaphragm weakness.

Why it matters

Potential benefit: If successful, this work could point to new ways to prevent or reverse diaphragm weakness in ventilated patients and help more people come off ventilators safely.

How similar studies have gone: Laboratory and pilot biopsy data support a role for the myosin 'super-relaxed' state and titin in diaphragm weakness, but translating these findings into therapies is still novel.

Where this research is happening

  • University of Arizona
    Tucson, United States
    Active

Researchers

  • Principal investigator: Ottenheijm, Coen — University of Arizona
  • Study coordinator: Ottenheijm, Coen

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.